Unresectable Colorectal Carcinoma (DBCOND0122786)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04704661	Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial	Ceralasertib Trastuzumab deruxtecan	treatment	1	recruiting
NCT06626256	STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma	Aldesleukin Cyclophosphamide Fludarabine	treatment	1	not_yet_recruiting
NCT05518032	Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)	Pembrolizumab	treatment	2	withdrawn
NCT04616183	LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer	Abemaciclib Cetuximab Temuterkib	treatment	1 / 2	active_not_recruiting
NCT04119830	Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer	Pembrolizumab Rintatolimod	treatment	2	withdrawn
NCT03992456	Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer	Panitumumab Regorafenib TAS-102 Tipiracil Trifluridine	treatment	2	active_not_recruiting
NCT04096417	Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations	Pemigatinib	treatment	2	active_not_recruiting
NCT04109924	TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study	Benzalkonium Bevacizumab Irinotecan TAS-102 Thymidine Tipiracil Trifluridine	treatment	2	active_not_recruiting
NCT05803382	Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers	Capecitabine	treatment	1	recruiting
NCT02595931	M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery	Berzosertib Camptothecin Irinotecan	treatment	1	active_not_recruiting
NCT05863195	Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial	Bevacizumab Cetuximab Floxuridine Fluorouracil Irinotecan Leucovorin Oxaliplatin Panitumumab	treatment	3	recruiting